FDA close to booster authorization for kids 12-15: report
Fox News
The U.S. Food and Drug Administration (FDA) is reportedly planning to expand eligibility for COVID-19 vaccine booster shots on Monday.
The Times, which cited "people familiar with the agency’s deliberations," also said that regulators are expected to authorize an extra shot of Pfizer’s vaccine for both adolescents and adults five months after receiving a second dose – shortened from the current interval of six months – and that children with immune deficiencies ages 5-11 would also be able to receive boosters.
The outlet reported that the decision was partially based on data from Israel that showed no serious safety concerns in the 12-15 age group, including myocarditis.
More Related News